Treatments

The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.

You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.

Become a Partner.

Country Product Indication Sponsor Date
Calcium acetate Hyperphosphatemia Pharmedic Company;28101 Ballard Road, Suite F;Lake Forest, Illinois, 60045 June 27, 1989
Coagulation factor IX Replacement treatment and prophylaxis of the hemorrhagic complications of hemophilia B Armour Pharmaceutical Company;500 Arcola Road, P.O. Box 1200;Collegeville, Pennsylvania, 19426 June 27, 1989
Interferon alfa-2a Chronic myeloid leukemia Hoffmann-La Roche, Inc.;340 Kingsland Street;Nutley, New Jersey, 07110 June 6, 1989
Granulocyte macrophage-colony stimulating factor Severe thermal injuries in patients with greater than 40% full or partial thickness burns Schering Corporation;2000 Galloping Hill Road;Kenilworth, New Jersey, 07033 June 6, 1989
Porfimer sodium For the photodynamic therapy of patients with primary or recurrent obstructing (either partially or completely) esophageal carcinoma QLT Phototherapeutics, Inc.;Lederle Laboratories, 401 North Middletown Road;Pearl River, New York, 10965 June 6, 1989
Bromhexine Mild to moderate keratoconjunctivitis sicca in patients with Sjogren's syndrome Boehringer Ingelheim Pharmaceuticals, Inc.;900 Ridgebury Road, Box 368;Ridgefield, Connecticut, 06877 May 15, 1989
Somatropin (rDNA) For the enhancement of nitrogen retention in hospitalized patients suffering from severe burns EMD Serono, Inc.;One Technology Place;Rockland, Massachusetts, 02370 May 3, 1989
Fludarabine phosphate Chronic lymphocytic leukemia Berlex Laboratories, Inc.;15049 San Pablo Avenue, P.O. Box 4099;Richmond, California, 94804 April 18, 1989
Fludarabine phosphate Treatment and management of patients with non-Hodgkins lymphoma Berlex Laboratories, Inc.;15049 San Pablo Avenue, P.O. Box 4099;Richmond, California, 94804 April 18, 1989
Recombinant soluble human CD4 (rCD4) AIDS in patients infected with HIV virus Genentech, Inc.;1 DNA Way;South San Francisco, California, 94080 March 23, 1989
Botulinum toxin type A Essential blepharospasm Porton International, Inc.;1155 15th Street, N.W., #315;Washington, District of Columbia, 20005 March 23, 1989
Antiepilepsirine Drug resistant generalized tonic-clonic epilepsy in children and adults Children's Hospital;700 Children's Drive;Columbus, Ohio, 43205 March 23, 1989
Somatropin for injection Short stature associated with Turner's syndrome Genentech, Inc.;1 DNA Way;South San Francisco, California, 94080 March 23, 1989
Aldesleukin Primary immunodeficiency disease associated with T-cell defects Prometheus Laboratories, Inc.;9410 Carroll Park Drive;San Diego, California, 92121 March 22, 1989
Cascara sagrada fluid extract Oral drug overdosage to speed lower bowel evacuation Intramed Corporation;102 Tremont Way;Augusta, Georgia, 30907 March 21, 1989
Epoetin alpha HIV associated anemia related to HIV infection or HIV treatment R. W. Johnson Pharmaceutical Research Institute;Route 202, P.O. Box 300;Raritan, New Jersey, 08869 March 7, 1989
Fluorouracil For use in combination with leucovorin for therapy of metastatic adenocarcinoma of the colon and rectum Lederle Laboratories;Division of American Cyanamid Company, 401 N. Middletown Road;Pearl River, New York, 10965 February 6, 1989
L-threonine Amyotrophic lateral sclerosis Tyson And Associates;12832 Chadron Avenue;Hawthorne, California, 90250 February 6, 1989
Botulism immune globulin Infant botulism California Department of Health Services;2151 Berkeley Way;Berkeley, California, 94704 January 31, 1989
Imciromab pentetate Detecting early necrosis as an indication of rejection of orthotopic cardiac transplants Centocor, Inc.;244 Great Valley Parkway;Malvern, Pennsylvania, 19355 January 25, 1989
Clonidine For continous epidural administration as adjunctive therapy with intraspinal opiates for the treatment of pain in cancer patients tolerant to, or unresponsive to, intraspinal opiates Roxane Laboratories, Inc.;PO Box 16532;Columbus, Ohio, 43216 January 24, 1989
Molgramostim AIDS patients with neutropenia due to the disease, AZTor ganciclovir Schering Corporation;2000 Galloping Hill Road;Kenilworth, New Jersey, 07033 January 24, 1989
Felbamate Lennox-Gastaut syndrome Wallace Laboratories;301B College Road East;Princeton, New Jersey, 08540 January 24, 1989
Mitolactol Invasive carcinoma of the uterine cervix Targent, Inc..;155 Lambert Drive;Princeton, New Jersey, 08540 January 23, 1989
Aerosolized pooled immune globulin Respiratory syncytial virus lower respiratory tract disease Pediatric Pharmaceuticals, Inc.;718 Bradford Avenue;Westfield, New Jersey, 07090 January 3, 1989